About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Arizona | 375 Studies

Clinical Trials Prostate CancerArizona

Prostate Cancer Clinical Trials in Arizona

Find 375 clinical trials for prostate cancer near Arizona. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 321-340 of 375 trials

RecruitingImmunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer PatientsThis early phase I is to find out how common vitamin D insufficiency is among African American patients with a history of prostate cancer that has not spread to other parts of the…NCT05045066·Scottsdale, Arizona and 1 other CompletedStudy of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerThis study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer.NCT00036556·Homewood, Alabama and 233 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedIsoflavones & Lycopene in Localized Prostate Ca:Prior to Radical ProstatectomyRATIONALE: Eating a diet rich in isoflavones, compounds found in soy foods, or lycopene, a substance found in tomatoes, may keep prostate cancer from growing.NCT00042731·Phoenix, Arizona and 4 others

CompletedStandard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the BoneThis study will assess different doses and regimens of radium-223 dichloride on the incidence of symptomatic skeletal events.NCT02023697·Scottsdale, Arizona and 67 others

CompletedTelephone Counseling: Men With Prostate Cancer & PartnersThe purpose of this project is to test a telephone delivered educational support program versus an education only program for improving symptom management and quality of life in…NCT00822510·Tucson, Arizona

TerminatedA Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate CancerEnthuse M0 is a large phase III clinical trial studying the efficacy of ZD4054 (Zibotentan) in hormone resistant prostate cancer (HRPC).NCT00626548·Tucson, Arizona and 321 others

TerminatedStudy to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate CancerThis study consists of a dose escalation study with an expansion phase to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), and preliminary…NCT03437941·Scottsdale, Arizona and 8 others

CompletedTesting the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringThis is a phase I-II trial to find the safety and activity of adding a new drug (neraparib) to the usual treatment (radiation combined with male hormone deprivation therapy) in…NCT04037254·Gilbert, Arizona and 94 others

CompletedCalcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate CancerRATIONALE: Preventing bone loss in patients who are undergoing androgen ablation for prostate cancer may decrease the risk of fractures and may help patients live more comfortably.NCT00043069·Scottsdale, Arizona and 113 others

UnknownStudy Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerThis Phase I/Ib study is a Multicenter, Open-label, Dose-Escalation, Safety, Pharmacodynamic and Pharmacokinetic Study of GZ17-6.02 Monotherapy and in Combination with…NCT03775525·Scottsdale, Arizona and 3 others

CompletedStudy to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate CancerThe purpose of the study is to determine whether lenalidomide is safe and effective for use in combination with docetaxel and prednisone for the treatment of subjects with…NCT00988208·Phoenix, Arizona and 209 others

CompletedPertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate CancerThis phase II trial tests how well pertuzumab, trastuzumab, hyaluronidase-zzxf and enzalutamide works in treating patients with castration-resistant prostate cancer that has…NCT05730712·Scottsdale, Arizona and 2 others

Active not recruitingA Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate CancerThis study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration…NCT03706365·Phoenix, Arizona and 111 others

CompletedA Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate CancerThis is a randomized, open-label study designed to assess the effects of sipuleucel-T when administered concurrently or sequentially with enzalutamide.NCT01981122·Tucson, Arizona and 18 others

RecruitingStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsThis is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity…NCT05176483·Phoenix, Arizona and 121 others

CompletedClinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor MalignanciesPhase 1 A: First-in-human phase 1 study to determine safety of NP-G2-044 when given orally on a daily X 28 days followed by a 14 day rest period.NCT03199586·Scottsdale, Arizona and 2 others

CompletedEfficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)The purpose of this study is to assess the efficacy and safety of navarixin (MK-7123) in combination with pembrolizumab (MK-3475) in adults with one of three types of solid…NCT03473925·Scottsdale, Arizona and 13 others

TerminatedVaccine Study of MVA-MUC1-IL2 in Patients With Prostate CancerThis study involves the use of an experimental product, TG4010.NCT00040170·Tucson, Arizona and 2 others

CompletedSafety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate CancerThe purpose of this study is to determine the safety and efficacy of enzalutamide vs bicalutamide in asymptomatic or mildly symptomatic patients with prostate cancer who have…NCT01664923·Birmingham, Alabama and 108 others

Active not recruitingStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsStudy of NGM831 as Monotherapy and in Combination with Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsNCT05215574·Gilbert, Arizona and 8 others

PreviousPage 17 of 19Next

Other Conditions in Arizona

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma